Intelligence / Healthtech / Device Recalls / Fresenius Medical Care Renal Therapies Group, LLC
Fresenius Medical Care Renal Therapies Group, LLC
9 Sept 2026: Class II recall · Citrasate, Liquid Acid Concentrate for Bicarbonate Hemodialysis: Product Numbers: 08-2251-CA, 08-3251-CA, 13-2251-CA; Liquid Acid Concentrate for Bicarbonate He. Recorded in the openFDA device enforcement reports.
- Reported
- 9 Sept 2026
- Recall Class
- Class II
- Product
- Citrasate, Liquid Acid Concentrate for Bicarbonate Hemodialysis: Product Numbers: 08-2251-CA, 08-3251-CA, 13-2251-CA; Liquid Acid Concentrate for Bicarbonate He
- Reason
- Complaints of blue-green discoloration in product
- Country
- United States
- Status
- Ongoing
- Reference
- Z-3093-2026
- Location
- Waltham, MA
A recall puts quality, regulatory, field service and communications under pressure at once.
- Class II leads with 660 of 741, then Class I (68).
- 235 added in the 30 days to 18 Nov 2026.
Find the decision makers at Fresenius Medical Care Renal Therapies Group, LLC
AOS maps the buying committee, finds verified work emails and drafts outreach that cites this quality signal, for your approval.
Across AOS Research
Other records for Fresenius Medical Care Renal Therapies Group, LLC in our registers.
More in Class II
Device Recalls
Source: openFDA device enforcement reports, data to 18 Nov 2026. Device recalls classified by FDA, by report date. Class I is the most serious. AOS shows what the public record says; it does not verify or endorse the company.